Investigators compared the risk of cancer onset in patients with lupus nephritis treated with calcineurin inhibitors vs ...

INDIANAPOLIS (WISH) — Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy that’s been used for cancer patients may help people with ...

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...

Please provide your email address to receive an email when new articles are posted on . Pancytopenia occurred in more than 13% of patients with systemic lupus erythematosus receiving immune checkpoint ...

The team at Charité – Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe systemic lupus erythematosus (SLE) after being treated with the cancer ...

Jennifer Le’s doctor ticked through a long checklist of head-to-toe symptoms as she examined Le in a Boston clinic last month. Was she experiencing brain fog? Headaches? What about hair loss, rashes ...

AGOURA HILLS, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTLC) announced today the peer reviewed publication of Transforming Growth Factor Beta 2 (TGFB2) mRNA Levels, in ...

Fox News Digital publishes an array of health pieces all week long on medical research, disease prevention, healthy eating, cutting-edge surgeries and more. We also feature personal stories of ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen McMahon, ...

The U.S. Food and Drug Administration (FDA) on Monday approved AstraZeneca Plc (NASDAQ: AZN) and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) in combination with pertuzumab for patients with a ...